Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,728 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.
Tanaka Y, Takeuchi T, Mimori T, Saito K, Nawata M, Kameda H, Nojima T, Miyasaka N, Koike T; RRR study investigators. Tanaka Y, et al. Among authors: takeuchi t. Ann Rheum Dis. 2010 Jul;69(7):1286-91. doi: 10.1136/ard.2009.121491. Epub 2010 Apr 1. Ann Rheum Dis. 2010. PMID: 20360136 Free PMC article.
Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
Sekiguchi N, Kawauchi S, Furuya T, Inaba N, Matsuda K, Ando S, Ogasawara M, Aburatani H, Kameda H, Amano K, Abe T, Ito S, Takeuchi T. Sekiguchi N, et al. Among authors: takeuchi t. Rheumatology (Oxford). 2008 Jun;47(6):780-8. doi: 10.1093/rheumatology/ken083. Epub 2008 Apr 3. Rheumatology (Oxford). 2008. PMID: 18388148
Rheumatoid arthritis and tumor necrosis factor alpha.
Abe T, Takeuchi T. Abe T, et al. Among authors: takeuchi t. Autoimmunity. 2001;34(4):291-303. doi: 10.3109/08916930109014698. Autoimmunity. 2001. PMID: 11905855 Free article. Review. No abstract available.
Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus.
Suzuki K, Nagasawa H, Kameda H, Amano K, Kondo T, Itoyama S, Tanaka Y, Takeuchi T. Suzuki K, et al. Among authors: takeuchi t. Rheumatology (Oxford). 2009 Feb;48(2):198-9. doi: 10.1093/rheumatology/ken421. Epub 2008 Nov 23. Rheumatology (Oxford). 2009. PMID: 19029134 No abstract available.
5,728 results